Sharon Ben Barouch, MD

Cancer, particularly non-Hodgkin lymphoma, remains a leading cause of death in patients with HIV who are being treated with antiretroviral therapy.

Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.